PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 73 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $22,000 | -78.8% | 5,700 | -81.2% | 0.00% | -80.0% |
| Q3 2019 | $104,000 | -61.6% | 30,400 | -47.3% | 0.01% | -47.4% |
| Q2 2019 | $271,000 | -7.8% | 57,700 | -34.4% | 0.02% | -17.4% |
| Q1 2019 | $294,000 | -29.7% | 87,900 | -44.1% | 0.02% | -32.4% |
| Q4 2018 | $418,000 | -52.5% | 157,200 | 0.0% | 0.03% | +70.0% |
| Q3 2018 | $880,000 | -30.0% | 157,200 | -36.6% | 0.02% | -16.7% |
| Q2 2018 | $1,258,000 | -26.3% | 248,037 | -0.9% | 0.02% | -27.3% |
| Q1 2018 | $1,708,000 | +154.9% | 250,367 | +182.0% | 0.03% | +153.8% |
| Q4 2017 | $670,000 | +41.6% | 88,773 | +8.1% | 0.01% | +44.4% |
| Q3 2017 | $473,000 | – | 82,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |